title: Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
abstract: CsA is a commonly used immunosuppressive drug known to possibly induce cholestatic side effects. Ursodeoxycholic acid (UDC), a nonhepatotoxic bile acid, has proved to be efficient for several types of cholestasis. The aim of this experiment was to evaluate the ability of tauroursodeoxycholate (TUDC) in preventing CsA-induced cholestasis on bile duct-cannulated rats. After bile flow stabilization, a bolus of 30 mg/kg CsA was given i.v. to one group (n = 7) and was associated with a 2 mumol/kg/min TUDC infusion in another group (n = 7). The control group was injected with CsA-solvent. CsA, as used here, had a rapid and marked cholestatic effect. However, both bile flow and bile salt secretion were significantly enhanced in the TUDC group when compared to the CsA alone-treated group and showed no difference with the solvent control group. In addition, TUDC significantly increased elimination of CsA and its metabolites in bile. In contrast to what was found for endogenous bile salts, TUDC uptake was not affected by CsA. The anticholestatic effect of TUDC probably resulted from preventing CsA-induced hepatocyte membrane damage and from easing biliary excretion of CsA. Such properties could be helpful for CsA-treated liver recipients who are especially exposed to cholestatic problems, and thus, to toxic CsA accumulation in the liver. Moreover, regulation of CsA elimination might prevent, in part, its general toxicity.
authors.affiliation: INSERM, 13009, Marseille, France.
authors.forename: P E
authors.initials: PE
authors.lastname: Queneau
authors.forename: P
authors.initials: P
authors.lastname: Bertault-Perès
authors.forename: E
authors.initials: E
authors.lastname: Mesdjian
authors.forename: A
authors.initials: A
authors.lastname: Durand
authors.forename: J C
authors.initials: JC
authors.lastname: Montet
mesh_terms: D000818:Animals; D001647:Bile Acids and Salts / Q000097:blood / Q000378:metabolism; D002756:Cholagogues and Choleretics; D002779:Cholestasis / Q000139:chemically induced*; D016572:Cyclosporine / Q000037:antagonists & inhibitors; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012996:Solutions; D013654:Taurine / Q000494:pharmacology*; D014580:Ursodeoxycholic Acid / Q000494:pharmacology*; D014783:Viscosity
chemical_list: D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D012996:Solutions; C030141:taurine-ursodeoxycholate conjugate; D013654:Taurine; D014580:Ursodeoxycholic Acid; D016572:Cyclosporine